Yanhai Xi,1,* Tingwang Jiang,2,* Birendra Chaurasiya,3 Yanyan Zhou,1 Jiangmin Yu,1 Jiankun Wen,1 Yan Shen,3 Xiaojian Ye,1 Thomas J Webster4

1Department of Spine Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, Peoples Republic of China; 2Department of Immunology and Microbiology, Institution of Laboratory Medicine of Changshu, Changshu, Jiangsu 215500, Peoples Republic of China; 3Department of Pharmaceutics, Center for Research Development and Evaluation of Pharmaceutical Excipients and Generic Drugs, China Pharmaceutical University, Nanjing, Peoples Republic of China; 4Department of Chemical Engineering, Northeastern University, Boston, MA, USA

*These authors contributed equally to this work

Correspondence: Xiaojian YeDepartment of Spine Surgery, Changzheng Hospital, Second Military Medical University, 360 Huntington Avenue, Shanghai, MA 200003, Peoples Republic of ChinaTel +86 1 381 734 6934Email xjyespine@smmu.edu.cn

Thomas J WebsterDepartment of Chemical Engineering, Northeastern University, Boston, MA 02115, USATel +1 617 373 6585Email th.webster@neu.edu

Abstract: Ankylosing spondylitis (AS) is a complex disease characterized by inflammation and ankylosis primarily at the cartilagebone interface. The disease is more common in young males and risk factors include both genetic and environmental. While the pathogenesis of AS is not completely understood, it is thought to be an immune-mediated disease involving inflammatory cellular infiltrates, and human leukocyte antigen-B27. Currently, there is no specific diagnostic technique available for this disease; therefore conventional diagnostic approaches such as clinical symptoms, laboratory tests and imaging techniques are used. There are various review papers that have been published on conventional treatment approaches, and in this review work, we focus on the more promising nanomedicine-based treatment modalities to move this field forward.

Keywords: ankylosing spondylitis, pathogenesis, genetic factors, environmental factors, treatment approaches

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Read this article:
Advances in nanomedicine for the treatment of ankylosing spondylitis | IJN - Dove Medical Press

Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nanorobots, for diagnosis, delivery, sensing or actuation purposes in a living organism. These can pass directly through the cellular membranes and interact with the cellular DNA and proteins, giving better desired results as compared to the traditional form of medicines. These nanomedicines are normally used across applications such as, diagnosis, targeted drug delivery and imaging.

The The Insight Partners market research report provides a comprehensive picture on Nanomedicines Market, from the global viewpoint, offering a forecast and statistic in terms of revenue during the forecast period. The report covers a descriptive analysis with detailed segmentation, complete research and development history, latest news and press releases. Furthermore, the study explains the future opportunities and a sketch of key players operating in the Nanomedicines market.

Nanomedicines Market

Get Sample PDF https://www.theinsightpartners.com/sample/TIPRE00004589/

Leading Nanomedicines marketPlayers:

Detailed segmentation of the market, on the basis of Type and Application and a descriptive structure of trends of the segments and sub-segments are elaborated in the report. It also provides the market size and estimates a forecast from the year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the Nanomedicines marketThe report assists in determining and analyzing the key market players portfolios with information such as company profiles, components and services offered, financial information for last three years, key developments in past five years, and helps in constructing strategies to gain competitive advantage. The market payers from Nanomedicines market are anticipated to gain lucrative growth opportunities in the future with the rising demand at the global level. Below mentioned is the list of few companies engaged in the Nanomedicines market.

The Nanomedicines market report is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2019 2027, considering 2017 as the base year and 2019 2027 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 16 countries across the mentioned regions. The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market.

Purchase This Report at https://www.theinsightpartners.com/buy/TIPRE00004589/

The report also includes the profiles of key equine healthcare market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

Answers that the report acknowledges:

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:Call: +1-646-491-9876Email:sales@theinsightpartners.com

Website:https://www.theinsightpartners.com/

More here:
Nanomedicines Market 2027 In-Depth Analysis with Booming Trends and Supporting Growth with Top Key Players AstraZeneca, Cristal Therapeutics, Ablynx ,...

Transparency Market Research (TMR) has published a new report titled, Microcatheter Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026. According to the report, the global microcatheter market was valued atUS$ 162.3 Mnin 2017 and is anticipated to reach nearlyUS$ 304.5 Mnby 2026, expanding at a CAGR of around 7.5% from 2018 to 2026. Rise in adoption of minimally invasive procedures, technological advancements, increase in target patient population are likely to fuel the global microcatheter market from 2018 to 2026. Improved hospital infrastructure in developed markets such asNorth AmericaandEurope, rise in medical tourism inAsia Pacific, and advantages of minimally invasive procedures are expected to drive the microcatheter market during the forecast period.

Get PDF Brochure for Research Insights athttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35942

Rise in Adoption of Minimally Invasive Surgeries to Propel Market

Embolization is a minimally invasive surgery that marks a significant advancement in medical technology. Embolization procedures are used in the treatment of cerebral aneurysms and peripheral vascular diseases. Adoption of minimally invasive surgeries has been increasing significantly due to various advantages including less post-operative pain, less blood loss, reduced hospital stay, and faster recovery. This is likely to propel the microcatheters market during the forecast period

Increase in target patient population and Technological Advancements

Increase in the geriatric population, which is prone to neurovascular and cardiovascular diseases, is projected to drive the microcatheter market. According to the National Institute of Neurological Disorders and Stroke, nearly 30,000 people in the U.S. suffer a brain aneurysm rupture each year.

Request a Custom Report athttps://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=35942

According to the American Heart Association, cardiovascular diseases account for around 17.3 million deaths each year, which is expected to increase to about 23.6 million by 2030. Technological advancements such as introduction of double coaxial guiding catheter technique, which is employed to treat chronic total occlusion (CTO) is driving the market. This technique places one guide catheter inside another. The advantages of passive support provided by a large guide catheter are combined with the ability to actively engage the smaller catheter into the target vessel. These developments are likely to add value to microcatheters and drive the global microcatheter market

Product Recall and Stringent Regulatory Requirement to Restrain Market

Several microcatheters witnessed recalls in the last few years due to defects in the products. This is expected to impact the demand for these devices. Product recalls also have a negative impact in the future profitability and adoption of these procedures by patients. InOctober 2016, Medtronic recalled certain lots of pipeline embolization device, Alligator retrieval device, and X-Celerator hydrophilic guide wire. The recall also included the stylet containing UltraFlow flow directed microcatheters and marathon flow directed microcatheters. Product approvals and launch of medical devices are governed by various regulations established by the U.S. FDA and other regulatory bodies operating in each country. The U.S. FDA continues to increase testing and documentation required for the clearance of devices. Similar regulations are noted in the European Union (EU),Japan, andChina. The various levels of approval processes can delay the product release in the market, which could have a negative impact on revenue

Request a Sample of Microcatheter Market:https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=35942

Market inAsia Pacificto Register Exponential Growth

In terms of revenue, the microcatheter market inAsia Pacificis expected to expand at a CAGR of 7.8% during the forecast period. Increase in product launches is expected to drive theAsia Pacificmicrocatheter market. In 2018, ASAHI received chronic total occlusion (CTO) approvals for Corsair Pro Micro catheters and its Coronary Guide Wires to the include MIRACLEbros series, CONFIANZA series, FIELDER series, and Gaia series. According to the World Health Organization, most of the financial burden in health care is the responsibility of governments of countries inAsia Pacific. For instance, inChina, more than 95% of health care coverage is under public insurance schemes, which lay emphasis on catastrophic diseases and inpatient services.

Request For Discount On This Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=35942

Boston Scientific Corporation,Codman Neuro, Medtronic, Biometrics and Asahi InteccUSA, Inc. to Lead the Market

The report also provides profiles of leading players operating in the global microcatheter market, which include Boston Scientific Corporation,Codman Neuro, Medtronic, Biometrics, Asahi InteccUSA, Inc., Merit Medical Systems, Inc., Stryker, Terumo Medical Corporation, Tokai Medical Products, Inc., and Penumbra, Inc.

View post:
Nanomedicine Market Overview On Product Performance 2025 - Health News Office

Pupils have been given a unique opportunity to find out more about nanotechnology at a special Swansea University workshop aimed at inspiring scientists of the future.

NanoBach brought Year 7 & 8 pupils from across Neath Port Talbot together with students who were able to demonstrate what nanotechnology is and how it can be applied on a wider scale in everyday life

Nanoscience is the study of extremely small things and can be used across all the other science fields, such as chemistry, biology, physics, materials science, and engineering. This event aimed to give children a better understanding and spark an interest in nanotechnology.

The event was developed by Professor Steve Conlan, head of enterprise and innovation at Swansea University Medical School, who had seen the positive impact of a similar schools event held as part of Italian conference NanoGaliato has attended over the years.

Hosted at Tata Europes Academy Building in Port Talbot, the day saw nanomedicine students and researchers from the University helping the pupils as they tried out a variety of fun experiments and activities.

Year 8 pupil Mindie James, from YsgolBro Dur, said: I have learned so much. I knew nothing about nanotechnology before today and now I know loads. I really enjoyed making UV bracelets and nanoparticles, it was awesome!

Professor Conlan said: NanoBach aims to inspire Waless next generation of nanoscientists. It explored the nanomedicine, nanoenergy and nanoenvironment, which cover many aspects of the future of science and medicine.

Nanobach is the Welsh edition of the Academia di Gagaliato Globales programme, and is inspired by Nanopicolla which is hosted annually in Calabria and we were excited to be the first country to host an Academia event outside Italy.

At the end of the event the youngsters were able to show off what they had learned to their families and members of the community including the Mayor and Mayoress of Neath Port Talbot Scott and Jemma Jones.

Councillor Jones said: This was a fine example of one of largest employers, Tata Steel, working with one of our local universities to bring schools together for such a fun, educational event. We are very grateful to the Medical School for showcasing the skills needed for the workforces of the future here in Neath Port Talbot.

Head of science at Ysgol Ystalyfera Richard Morgan added: There were so many hands-on activities for the pupils, they were very engaged. This was an excellent learning opportunity outside of the classroom which gave them a great insight into possible careers and future study options.

Professor Conlan said the event had been such a success that plans were already under way for next years NanoBach.

Excerpt from:
University gives pupils first-hand experience of nanotechnology - Wales247

New York City, NY: October 18, 2019-InternationalNanomedicine MarketResearch Report 2019 liable for its analysis which furnishes an overall assessment of Nanomedicine market including sales and evolving business sectors. The Nanomedicine report consists business overview, product offering, Nanomedicine revenue share, strategies, and service offering of these important key players in market.

This report includes several essential sections from the worldwide Nanomedicine market. Global market trends are examined with recently obtainable data concerning the amount of both Nanomedicine businesses and their market share. The report reviews how current approaches in Nanomedicine economy, ethical troubles, and also the challenges and hurdles which could limit the market.

GetNanomedicineMarketInsights That Actually Matters: To Know More RequestSample Copy@https://marketresearch.biz/report/nanomedicine-market/request-sample

Top Manufacturers (2019-2028) :

Abbott Laboratories, Ablynx NV, Abraxis BioScience, Inc., Celgene Corporation, Teva Pharmaceutical Industries Limited, GE Healthcare Limited, Merck & Co., Inc., Pfizer Inc., Nanosphere, Inc., Johnson & Johnson Services, Inc.

Geographically this report is classified into various essential regions, jointly with income (Mn/Bn USD), extension speed and market share (percent) manufacture, and ingestion of worldwide Nanomedicine industry in these regions, by 2017 to 2026 (projected), including North America, Europe, Middle East and Africa, Asia-Pacific and South America as well as its share (percent) and also CAGR for its projected period 2019 to 2028.

Global Nanomedicine Market Analysis by Sections:

Global nanomedicine market segmentation by product: Therapeutics, Regenerative medicine, In-vitro diagnostics, In-vivo diagnostics, Vaccines. Global nanomedicine market segmentation by application: Clinical Oncology, Infectious diseases, Clinical Cardiology, Orthopedics, Others

Remarkable highlights of Nanomedicine Market Report:

international Nanomedicine Market Overview

This Nanomedicine study supplies point-by-point assessment for modifying competitive dynamics

Marketing-strategy Analysis, Distributors/Traders

Economy effect features diagnosis

Industrial Chain, Nanomedicine Best sourcing strategy and down-stream buyers

Market contest by Players

From the Nanomedicine market research reports, the following points are included with detailed study at every stage:

Manufacturing Analysis Initiation of this Nanomedicine is studied depending on top countries, types, and applications. Here, price analysis of varied global Nanomedicine market vital players will be additionally covered.

Revenue and Sales Evaluation Both, earnings and sales are studied for different elements of this worldwide Nanomedicine market. Still another significant facet, the price that plays an essential role in the sales creation can be appraised in this section for several regions.

Segments and Effectiveness In continuation of using earnings, this report studies furnish and ingestion to its Nanomedicine market. This report also sheds light on the difference between consumption and supply, export and import data.

Competition In this section, many global Nanomedicine industry-leading players have been studied depending on their company profile, product portfolio, capacity, cost, and earnings.

Other Analysis Apart from the above vital information, demand and supply investigation to the global Nanomedicine economy, contact information from leading manufacturers, providers and key consumers can also be awarded.

Inquire/Speak To Expert for Further Detailed Information About Nanomedicine Report :https://marketresearch.biz/report/nanomedicine-market/#inquiry

Reasons to Purchase this Report:

It helps to know that the vital Nanomedicine product sections along with their future predictions.

It aids for making informed business decisions by utilizing a complete analysis of market segments and from having whole understanding of Nanomedicine industry.

It poses a forward-looking probability on distinct facets controlling and market development.

This poses a more thorough analysis of this shifting contest dynamics and keeps you in front of competitions.

International Nanomedicine Market Forecast (2019-2028)

This poses a ten-year Nanomedicine prediction assessment fundamentally based mostly on the way the segments are forecast.

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us atcontact@wiredrelease.com.

Read more from the original source:
Nanomedicine Market Demand , Economy effect, Research Discoveries with Industrial Chain By 2028 - Healthcare News

Nanomedicine with Sustained Efficacy in Oncology in Late-stage Preclinical Development
Speaker: Dr. Cristianne JF Rijcken, PharmD, CEO, Cristal Delivery B.V., Maastricht (NL) CLINAM 7/ 2014, 7th Conference and Exhibition, June 23-25, 2014.

By: TAUVOD

More:
Nanomedicine with Sustained Efficacy in Oncology in Late-stage Preclinical Development - Video

Therapies on a nano scale rely on engineered nanoparticles designed to package and deliver drugs to exactly where theyre needed.

A recent US study of people treated for cancer as children from the 1970s to 1999 showed that although survival rates have improved over the years, the quality of life for survivors is low. It also showed this was worse for those who were treated in the 1990s.

About 70% of childhood cancer survivors experience side effects from their treatment, including secondary cancers. And as survival rates improve, the worldwide population of childhood cancer survivors is growing.

Side effects cause stress for survivors and families and increase demand on health systems. But an emerging area of medicine, nanomedicine, offers hope for better childrens cancer treatment that will have fewer side effects and improve quality of life for survivors.

Nanomedicine is the application of nanomaterials, or nanoparticles, to medicine. Nanoparticles are a form of transport for drugs and can go places drugs wouldnt be able to go on their own.

Nano means tiny. A nanometre (nm) is one-billionth of a metre. Nanoparticles used for drug delivery are usually in the 20 to 100 nanometre range, although this can vary depending on the design of the nanoparticle.

Nanoparticles can be engineered and designed to package and transport drugs directly to where theyre needed. This targeted approach means the drugs cause most harm in the particular, and intended, area of the tumour they are delivered to. This minimises collateral damage to surrounding healthy tissues, and therefore the side effects.

The first cancer nanomedicine approved by the US Food and Drug Administration was Doxil. Since 1995, it has been used to treat adult cancers including ovarian cancer, multiple myeloma and Karposis sarcoma (a rare cancer that often affects people with immune deficiency such as HIV and AIDS).

Currently, there is a stream of new nanomedicine treatments for adult cancers in clinical trials (trials in humans), or on the market. But only a limited number of these have been approved for childrens cancers, although this is arguably where nanomedicines strengths could have the most benefit.

The nanoparticle drug-delivery systems can work in different ways. Along with carrying the drug for delivery, nanoparticles can be engineered to carry specific compounds that will let them bind, or attach, to molecules on tumour cells. Once attached, they can safety deliver the drug to the specific tumour site.

Nanoparticles can also help with drug solubility. For a drug to work, it must be able to enter the bloodstream, which means it needs to be soluble. For example, the cancer drug paclitaxel (Taxol) is insoluble so has to be dissolved in a delivery agent to get into the blood. But this agent can cause allergic reactions in patients.

To overcome these issues, chemists have developed a nanoparticle out of the naturally occurring protein albumin. It carries the paclitaxel and makes it soluble but without the allergic reactions.

Tumours commonly have disordered and leaky blood vessels sprouting through and off them. These vessels allow chemotherapy drugs to readily enter the tumour, but because chemotherapy molecules are so small, they also diffuse through the vessels and out of the tumour, attacking surrounding tissues. Nanoparticles are larger molecules that get trapped inside the tumour, where they do all the damage.

Once they have delivered their drug cargo to cells, nanoparticles can be designed to break down into harmless byproducts. This is particularly important for children who are still developing.

Nanoparticles vary in characteristics like shape and size. Researchers need to match the right nanoparticle to the drug its to deliver and the particular tumour.

An array of nanoparticle structures are currently being engineered. One example of an interesting structure is the shape of a DNA origami. Because DNA is a biological material, nanoparticles engineered into DNA origami shapes wont be seen as foreign by the immune system. So these can transport a drug to diseased cells while evading the bodys immune system, therefore lessening the side effects of drugs.

Another example of nanomedicine structures are polymeric nanocarriers. We have recently identified a gene that promotes the growth of tumours, cancer spread and resistance to chemotherapy in pancreatic cancers.

We used a nanomedicine called a polymeric nanocarrier and combined it with a drug that silences the cancer gene. We packaged this up to form a nanomedicine and delivered the drugs into the tumour.

These nanomedicines reduced the expression of the cancer gene, blocked tumour growth and reduced the spread of pancreatic cancer. But we also showed that polymeric nanocarriers can be combined in the lab with other gene-silencing drugs. This means the method can be used for a range of other gene-based cancers.

In standard treatment for childrens cancer, chemotherapy drugs are often prescribed at the maximum tolerable dose for a childs age or size, based on adult dosages. But children arent small adults. The processes underlying childrens growth and development might lead to a different effect and response to a chemotherapy drug not seen in adults.

Also, if a child becomes resistant to a drug and theyre on the maximum tolerable dose, theres no scope to increase it without toxic side effects. By packaging up drugs and moving them through the body directly to diseased cells to reduce collateral damage, in theory, nanomedicine allows higher doses of drugs to be used.

Nanomedicine has great potential to safely treat childrens cancer. However, it is currently stymied by too little research. About two-thirds of research attention in nanomedicine therapeutics, of more 250 nanomedicine products, is focused on cancer. Yet this isnt translating into new cancer treatments for children coming to market.

But we are making progress. Our work is exploring the design of nanoparticles to deliver gene-silencing drugs to treat the most common brain cancer in children medulloblastoma.

Were also working on nanomedicines for other significant childhood cancers. These include drug-refractory acute lymphoblastic leukaemia, the most common childhood cancer, and neuroblastoma, the cancer that claims more lives of those under five than any other.

See more here:
Explainer: what is nanomedicine and how can it improve childhood cancer treatment? - The Conversation AU

Regulatory News:

NANOBIOTIX (Paris:NANO) (Euronext: NANO ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced its unaudited revenues for the second quarter of 2017.

Income statement

Activity and results

Total revenues for the second quarter amounts to 58,645, which is fully in line with the Companys expectations.

For this period, most of the revenues are generated from services that Nanobiotix crossed-charged to its partners as per its operational activities.

In May, Nanobiotix announced a first set of clinical data from its immuno-oncology (IO) program, showing the potential ability of NBTXR3 to transform "cold tumors into "hot tumors. The new clinical data and previous pre-clinical data indicate that NBTXR3 could play a key role in oncology and could become a backbone in immuno-oncology.

Nanobiotix presented the results of the Phase I/II head and neck cancer trial with its lead product candidate, NBTXR3, at the American Society of Clinical Oncology (ASCO), Chicago in June. The excellent safety profile demonstrated in this elderly and frail population so far indicates that NBTXR3 would represent a valuable option to preserve and improve patients Quality of Life compared to other treatments. This safety profile also opens up opportunities for combinations with different types of treatments. These encouraging results point towards a positive improvement of loco-regional Control, impacting Overall Survival of the patients.

Nanobiotix is filing a protocol amendment of this study to include 44 additional patients in an expansion to demonstrate the efficacy of NBTXR3. Nanobiotix is opening 12-15 additional sites in Europe to expand the development of this indication, and plans to expand this study in the US.

Finally, in mid-June, Nanobiotix presented new translational data at the "Immunotherapy workshop - Incorporating Radiation Oncology into Immunotherapy co-sponsored by the American Society of Radiation Oncology (ASTRO), the National Cancer Institute (NCI) and the Society for Immunotherapy of Cancer (SITC) in Bethesda, Maryland, USA. Taken together, these non-clinical and preliminary clinical results confirm that NBTXR3 plus radiotherapy could efficiently prime an adaptive antitumor immune response, turning "cold tumors in "hot tumors. Additionally, these results suggest that the physically-induced response and subsequent immune activation triggered by the NBTXR3 treatment could be generic. NBTXR3 with radiotherapy could transform tumors into an effective in situ vaccine, opening up very promising perspectives in the treatment of local cancer and metastases.

-Ends-

Next financial press release: revenue for the first half of 2017 to be released on August 31, 2017.

About NANOBIOTIX: http://www.nanobiotix.com

Nanobiotix (Euronext: NANO / ISIN: FR0011341205) is a late clinical-stage nanomedicine company pioneering novel approaches for the treatment of cancer. The Companys first-in-class, proprietary technology, NanoXray, enhances radiotherapy energy with a view to provide a new, more efficient treatment for cancer patients.

NanoXray products are compatible with current radiotherapy treatments and are meant to treat potentially a wide variety of solid tumors including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, glioblastoma, etc., via multiple routes of administration.

NBTXR3 is being evaluated in: soft tissue sarcoma (STS), head and neck cancers, prostate cancer, and liver cancers (primary and metastases). Additionally, head and neck cancer and rectal cancer trials led by Nanobiotixs Taiwanese partner, PharmaEngine, are underway in the Asia Pacific region. The Company has filed in August 2016 for market approval (CE Marking) in Europe for its lead product NBTXR3.

The Company started in 2016 a new preclinical research program in Immuno-oncology with its lead product NBTXR3, which could have the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (ISIN: FR0011341205, Euronext ticker: NANO, Bloomberg: NANO: FP). The Company Headquarter is based in Paris, France. Affiliate in Cambridge, United States.

Disclaimer

This press release contains certain forward-looking statements concerning Nanobiotix and its business. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the reference document of Nanobiotix filed with the French Financial Markets Authority (Autorit des Marchs Financiers) under number D.17-0470 on April 28, 2017 (a copy of which is available on http://www.nanobiotix.com) and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.

This press release and the information that it contains do not constitute an offer to sell or subscribe for, or a solicitation of an offer to purchase or subscribe for, Nanobiotix shares in any country. At the moment NBTXR3 does not bear a CE mark and is not permitted to be placed on the market or put into service until NBTXR3 has obtained a CE mark.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170712006094/en/

More:
Nanobiotix Revenues for the 2nd Quarter of 2017 - Markets Insider

Download Medical Nanotechnology and Nanomedicine Perspectives in Nanotechnology PDF
Click Here to Download : http://bit.ly/1tNYJsf.

By: Brady Ibrahim

Read the original here:
Download Medical Nanotechnology and Nanomedicine Perspectives in Nanotechnology PDF - Video

Top Nanomedicine researcher Dr. Mark Dewhirst speaks at OSU
Mark W. Dewhirst, DVM, PhD, is one of the top researchers in the field of nanomedicine. He is known for developing the thermally sensitive liposome that was ...

By: OStateTV

Link:
Top Nanomedicine researcher Dr. Mark Dewhirst speaks at OSU - Video

Nanomedicine and IP
Speaker: Shulamit Hirsch, IP Director, Ramot Day 5: Success Stories and the Road to Commercialization "Summer School on Nanomedicine and Innovation", The Marian Gertner Institute for Medical...

By: TAUVOD

See more here:
Nanomedicine and IP - Video

#5: Cutting Edge of Science, Homeopathy, Nanomedicine
Part 2: A presentation at San Francisco #39;s prestigious Commonwealth Club (September 17, 2014). The body of evidence for homeopathy and nanopharmacology is so much larger than most people ...

By: Dana Ullman

Read this article:
#5: Cutting Edge of Science, Homeopathy, & Nanomedicine - Video

Final Report will add the analysis of the impact of COVID-19 on this industry.

Global Healthcare Nanotechnology (Nanomedicine) Market Research Report 2015-2026 is a historical overview and in-depth study on the current & future market of the Healthcare Nanotechnology (Nanomedicine) industry. The report represents a basic overview of the Healthcare Nanotechnology (Nanomedicine) market share, status, competitor segment with a basic introduction of key vendors, top regions, product types and end industries. This report gives a historical overview of the Healthcare Nanotechnology (Nanomedicine) market trends, growth, revenue, capacity, cost structure, and key drivers analysis.

Request a sample copy of the report https://www.industryresearch.biz/enquiry/request-sample/15878206

The report offers detailed coverage of the Global Healthcare Nanotechnology (Nanomedicine) market which includes industry chain structure, definitions, applications, and classifications. The global Healthcare Nanotechnology (Nanomedicine) market analysis is provided for the international markets including development trends, competitive landscape analysis, investment plan, business strategy, opportunity, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, industry share, policy, price, revenue and gross margins.

It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.

Market Analysis and Insights: Global Healthcare Nanotechnology (Nanomedicine) Market

The global Healthcare Nanotechnology (Nanomedicine) market size is projected to reach US$ 215130 million by 2026, from US$ 194920 million in 2020, at a CAGR of 9.6%% during 2021-2026.

Global Healthcare Nanotechnology (Nanomedicine) Scope and Market Size

Healthcare Nanotechnology (Nanomedicine) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Healthcare Nanotechnology (Nanomedicine) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Enquire before purchasing this report https://www.industryresearch.biz/enquiry/pre-order-enquiry/15878206

Report Scope And Segmentation Table:

Types:

Nanomedicine, Nano Medical Devices, Nano Diagnosis, Other,

Applications:

Anticancer, CNS Product, Anti-infective, Other,

Key Players:

Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, SmitH& Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Takeda, Ipsen, Endo International,

CAGR 2021-2026:

9.6%

Market Size 2020:

USD 194920 million

Market Size 2026:

USD 215130 million

Historical Years:

2015-2019

Base Year:

2019

With tables and figures helping analyze worldwide Global Healthcare Nanotechnology (Nanomedicine) market growth, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Purchase this report (Price 3900 USD for a single-user license) https://www.industryresearch.biz/purchase/15878206

Healthcare Nanotechnology (Nanomedicine) Market Report Contains Following Points in TOC:

Chapter 1: Healthcare Nanotechnology (Nanomedicine) Market Product Overview, Market Segment, Size, Sales, Growth Rate, Price by Type

Chapter 2: Global Healthcare Nanotechnology (Nanomedicine) Market Competition, Sales, Price, Base Distribution, Sales Area, Product Types, and Trends by Company

Chapter 3: Healthcare Nanotechnology (Nanomedicine) Company Basic Information, Manufacturing Base and Competitors, Product Category, Applications and Specifications, Price and Gross Margin (2015-2026)

Chapter 4: Healthcare Nanotechnology (Nanomedicine) Market Status, Size, CAGR, Revenue, Price, Gross Margin and Outlook by Regions

Chapter 5: Healthcare Nanotechnology (Nanomedicine) Market Sales, and Share Segment by Application/End Users

Chapter 6: Global Healthcare Nanotechnology (Nanomedicine) Market Sales, Revenue, Growth Rate Forecast (2021-2026)

Chapter 7: Healthcare Nanotechnology (Nanomedicine) Upstream Raw Materials, Price, Key Suppliers, Cost Structure, Manufacturing Expenses, Industrial Chain Analysis

Chapter 8: Marketing Strategy Analysis, Distributors

Chapter 9: Research Findings and Conclusion

Detailed TOC of Global Healthcare Nanotechnology (Nanomedicine) Market @ https://www.industryresearch.biz/TOC/15878206

About Us:

Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided todays businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors.Industry Research is the credible source for gaining the market reports that will provide you with the lead your business needs.

Contact Info:

Name: Mr. Ajay More

E-mail: [emailprotected]

Organization: Industry Research Biz

Phone: US +1424 253 0807 / UK +44 203 239 8187

Our Other Reports:

Geranium Oil Market 2020 Global Industry Trends, Future Growth,,

Healthcare BPO Market Size 2020 Business Strategies, Progression,

Skidders Market Size 2020 Global Industry Share, Outlook, Trends Evaluation, Geographical Segmentation, Business Challenges and Opportunity Analysis till 2026

Oil-free Centrifugal Chillers Market Size 2020 Growing Rapidly with Modern Trends, Development, Investment Opportunities, Share, Revenue, Demand and Forecast to 2026 Says Industry Research Biz

Mechanical Linear Actuators Market Size 2020 Analysis By Worldwide Industry Trends, Share, Gross Margin, Future Demand, Investment Opportunities, Analysis and Forecast by Top Leading Players till 2025

See original here:
Global Healthcare Nanotechnology (Nanomedicine) Market 2020: Key Manufacturers, Industry Share, Size, Growth Factors, Regional, and Competitive...

The report is designed to provide a holistic view of the Healthcare Nanotechnology market 2021-2026. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). High-level interpretation of Healthcare Nanotechnology market attributes using proprietary tools such as the Penetration Mapping Index, and other successful representational tools such as Porters Five Forces Analysis, SWOT, PESTEL, Ansoffs Matrix, etc. Regional estimates and forecasts & trend analysis for each country and region are also available in the study. The impact of the COVID-19, and also forecasts its recovery post-COVID-19. The report also presents forecasts for Healthcare Nanotechnology investments from 2021 till 2026.

Top Companies in the Global Healthcare Nanotechnology Market:Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International.

Over the next five years, the Healthcare Nanotechnology market will register a 9.9% CAGR in terms of revenue, the global market size will reach US$ 251360 million by 2025, from US$ 172260 million in 2019.

Market OverviewIt is defined as the study of controlling, manipulating, and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

Get Free Sample PDF Copy of Latest Research on Healthcare Nanotechnology Market 2020 Before the purchasehttps://www.marketinsightsreports.com/reports/02012579460/global-healthcare-nanotechnology-market-growth-status-and-outlook-2021-2026/inquiry?Mode=A46

Market InsightsNanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.The classification of Healthcare Nanotechnology includes Nanomedicine, Nano Medical Devices, Nano Diagnosis, and Other product. And the sales proportion of Nanomedicine in 2017 is about 86.5%, and the proportion is in increasing trend from 2013 to 2017.

The Healthcare Nanotechnology market can be divided based on product types and Its sub-type, major applications and Third-Party usage area, and important regions.

This report segments the global Healthcare Nanotechnology Market based on Typesare:NanomedicineNano Medical DevicesNano DiagnosisOthers

Nanomedicine has the highest percentage of revenue by type, with more than 86% in 2019.

Based on Application, the Global Healthcare Nanotechnology Market is Segmented into:AnticancerCNS ProductAnti-infectiveOthers

According to the application, anticancer and CNS products accounted for 17.56% and 22.70% of the market in 2019 respectively.

(Exclusive Offer: Flat 20% discount on this report)Inquire for Discounthttps://www.marketinsightsreports.com/reports/02012579460/global-healthcare-nanotechnology-market-growth-status-and-outlook-2021-2026/discount?Mode=46

Regions are covered By Healthcare Nanotechnology Market Report 2021 to 2026.

North America, Europe, China, Japan, Southeast Asia, India.North America (USA, Canada, and Mexico).Europe (Germany, France, UK, Russia and, Italy).Asia-Pacific (China, Japan, Korea, India and, Southeast Asia).

The Total Addressable Market (TAM) For estimating the market size two approaches are used: Bottom-up and Top-down approach. In the Bottom-up approach, the consumption of in the various segments is taken into account. The regional, segment-wise, and end-user uptake/consumption is taken into account for this approach. This is then totaled to arrive at the TAM for this approach. In the Top-down approach, the company-wise production in terms of both value and volume is taken into account and totaled for arriving at the TAM. This data is then bifurcated based on the consumption in the various market segments.

Significant Features that are under Offering and Key Highlights of the Reports:

-Detailed overview of Healthcare Nanotechnology Market-Changing the Healthcare Nanotechnology market dynamics of the industry-In-depth market segmentation by Type, Application, etc.-Historical, current, and projected Healthcare Nanotechnology market size in terms of volume and valueRecent industry trends and developments-Competitive landscape of Healthcare Nanotechnology Market-Strategies of key players and product offerings-Potential and niche segments/regions exhibiting promising growth.

Frequently Asked Questions about the Healthcare Nanotechnology market:

What are the recent developments and government policies? What are the top trends in the Healthcare Nanotechnology market? What is the growth rate of the market? Which Is the Most potential market segment? Which are the top industry players in the Healthcare Nanotechnology market? Which region would offer high growth for vendors in themarket?

The report has 150 tables and figures browse the report description and TOChttps://www.marketinsightsreports.com/reports/02012579460/global-healthcare-nanotechnology-market-growth-status-and-outlook-2021-2026?Mode=46

Customization of the Report: This report can be customized as per your needs for additional data up to 5 companies or 5 countries or nearly 40 analyst hours.

ABOUT US

MarketInsightsReportsprovides syndicated market research on industry verticals includingHealthcare, Information and Communication Technology (ICT), Technology, and Media, Chemicals, Materials, Energy, Heavy Industry, etc.MarketInsightsReportsprovides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:Irfan Tamboli (Sales Manager) Market Insights ReportsPhone: + 1704 266 3234 | +91-750-707-8687sales@marketinsightsreports.com | irfan@marketinsightsreports.com

Read this article:
Healthcare Nanotechnology Market Competitive Research And Precise Outlook 2021 To 2026 KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper

Nanomedicine Market 2020 report share informative Covid-19 Outbreak data figures as well as important insights regarding some of the market component which is considered to be future course architects for the market. This includes factors such as market size, market share, market segmentation, significant growth drivers, market competition, different aspects impacting economic cycles in the market, demand, expected business up-downs, changing customer sentiments, key companies operating in the Nanomedicine Market, etc. In order to deliver a complete understanding of the global market, the report also shares some of the useful details regarding regional as well as significant domestic markets. The report presents a 360-degree overview and SWOT analysis of the competitive landscape of the industries.

Top Key players of Nanomedicine Market Covered In The Report:GE HealthcareJohnson & JohnsonMallinckrodt plcMerck & Co. Inc.Nanosphere Inc.Pfizer Inc.Sigma-Tau Pharmaceuticals Inc.Smith & Nephew PLCStryker CorpTeva Pharmaceutical Industries Ltd.UCB (Union chimique belge) S.A Key Market Segmentation of Nanomedicine:

Key Product type

Regenerative MedicineIn-vitro & In-vivo DiagnosticsVaccinesDrug Delivery

Market by Application

Clinical CardiologyUrologyGeneticsOrthopedicsOphthalmology

Nanomedicine Market Region Mainly Focusing:

Europe Nanomedicine Market (Austria, France, Finland, Switzerland, Italy, Germany, Netherlands, Poland, Russia, Spain, Sweden, Turkey, UK), Asia-Pacific and Australia Nanomedicine Market (China, South Korea, Thailand, India, Vietnam, Malaysia, Indonesia, and Japan), The Middle East and Africa Nanomedicine Market (Saudi Arabia, South Africa, Egypt, Morocco, and Nigeria), Latin America/South America Nanomedicine Market (Brazil and Argentina), North America Nanomedicine Market (Canada, Mexico, and The USA)

Factors such as industry value chain, key consumption trends, recent patterns of customer behaviors, overall spending capacity analysis, market expansion rate, etc. The report also incorporates premium quality data figures associated with financial figures of the industry including market size (in USD), expected market size growth (in percentage), sales data, revenue figures and more. This might enable readers to reach quicker decisions with data and insights at hand.

Buy Full Report Now @ https://www.qurateresearch.com/report/buy/HnM/nanomedicine-market/QBI-99S-HnM-770883/

(A free report data (as a form of Excel Datasheet) will also be provided upon request along with a new purchase.)

Key Highlights from Nanomedicine Market Study:

Income and Sales Estimation Historical Revenue and deals volume is displayed and supports information is triangulated with best down and base up ways to deal with figure finish market measure and to estimate conjecture numbers for key areas shrouded in the Nanomedicine report alongside arranged and very much perceived Types and end-utilize industry. Moreover, macroeconomic factor and administrative procedures are discovered explanation in Nanomedicine industry advancement and perceptive examination.

Assembling Analysis The Nanomedicine report is presently broke down concerning different types and applications. The Nanomedicine market gives a section featuring the assembling procedure examination approved by means of essential data gathered through Industry specialists and Key authorities of profiled organizations.

Competition Analysis Nanomedicine Leading players have been considered relying upon their organization profile, item portfolio, limit, item/benefit value, deals, and cost/benefit.

Demand and Supply and Effectiveness Nanomedicine report moreover gives support, Production, Consumption and (Export and Import).

Major Points Covered in Table of Contents:

Nanomedicine Market OverviewMarket Competition by ManufacturersProduction Market Share by RegionsConsumption by RegionsGlobal Nanomedicine Production, Revenue, Price Trend by TypeGlobal Nanomedicine Market Analysis by ApplicationsCompany Profiles and Key Figures in Nanomedicine BusinessNanomedicine Manufacturing Cost AnalysisMarketing Channel, Distributors, and CustomersMarket DynamicsGlobal Nanomedicine Market ForecastResearch Findings and ConclusionMethodology and Data Source

In a word, the Nanomedicine Market report provides major statistics on the state of the Nanomedicine industry with a valuable source of guidance and direction for companies and individuals interested in the market. At the end, Nanomedicine Market Report delivers a conclusion which includes Research Findings, Market Size Evaluation, Global Market Share, Consumer Needs along with Customer Preference Change, Data Source. These factors will raise the growth of the business overall.

Contact Us:

Web:www.qurateresearch.comE-mail:[emailprotected]Ph: US +13393375221

Note: In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Read more from the original source:
Nanomedicine Market | Covid-19 Impact | Demand, Cost Structures, Latest trends, and Forecasts to 2026 | GE Healthcare, Johnson & Johnson,...

Radiocontrast Agent Market 2020: Latest Analysis

Chicago, United States:-TheRadiocontrast Agent market report5 Years Forecast [2020-2025]focuses on theCOVID19 Outbreak Impact analysis of key points influencing the growth of the market. The research report on the Radiocontrast Agent Market is a deep analysis of the market. This is a latest report, covering the current COVID-19 impact on the Radiocontrast Agent market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. Experts have studied the historical data and compared it with the changing market situations. The report covers all the necessary information required by new entrants as well as the existing players to gain deeper insight.

Furthermore, the statistical survey in the report focuses on product specifications, costs, production capacities, marketing channels, and market players. Upstream raw materials, downstream demand analysis, and a list of end-user industries have been studied systematically, along with the suppliers in this market. The product flow and distribution channel have also been presented in this research report.

Top Players of Radiocontrast Agent Market are studied:GE Healthcare (US)Bracco Imaging (Italy)Bayer HealthCare (Germany)Guerbet (France)Lantheus (US)Daiichi Sankyo (Japan)Unijules Life Sciences (India)J.B. Chemicals and Pharmaceuticals (India)Spago Nanomedicine (Sweden)Taejoon Pharm (South Korea)Jodas (India)Magnus Health (India)

>>> Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Radiocontrast Agent Market:

What Our Report Offers:

Note: Covid-19 pandemic affects most industries in the globe. Here at acquire market research we offer you comprehensive data of related industry which will help and support your business in all possible ways.Due to the pandemic of COVID-19 businesses have seen a decrease in their profits. While our intention is to help businesses regain their profits we also provide information regarding the COVID-19 virus to help our customers stay safe during the pandemic

Radiocontrast AgentSegmentation by Product

Barium-based Radiocontrast AgentIodinated Radiocontrast AgentGadolinium-based Radiocontrast AgentMicrobubble Radiocontrast AgentX-ray/Computed Tomography (CT)Magnetic Resonance Imaging (MRI)Ultrasound

Radiocontrast AgentSegmentation by Application

RadiologyInterventional RadiologyInterventional Cardiology

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Benefits of Buying this Market Research Report:

Our exploration specialists acutely ascertain the significant aspects of the global Radiocontrast Agent market report. It also provides an in-depth valuation in regards to the future advancements relying on the past data and present circumstance of Radiocontrast Agent market situation. In this Radiocontrast Agent report, we have investigated the principals, players in the market, geological regions, product type, and market end-client applications. The global Radiocontrast Agent report comprises of primary and secondary data which is exemplified in the form of pie outlines, Radiocontrast Agent tables, analytical figures, and reference diagrams. The Radiocontrast Agent report is presented in an efficient way that involves basic dialect, basic Radiocontrast Agent outline, agreements, and certain facts as per solace and comprehension.

Table of Contents.

Report Overview:It includes major players of the globalkeywordmarket covered in the research study, research scope, and market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the globalkeywordmarket. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the globalkeywordmarket are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the globalkeywordmarket by application, it gives a study on the consumption in the globalkeywordmarket by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the globalkeywordmarket are profiled in this section. The analysts have provided information about their recent developments in the globalkeywordmarket, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the globalkeywordmarket as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the globalkeywordmarket as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the globalkeywordmarket.

Key Findings:This section gives a quick look at the important findings of the research study.

Get Full Customize report @ https://www.reporthive.com/request_customization/2345748

Why Go For Report Hive Research?

Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Get in Touch with Us :

Report Hive Research

500, North Michigan Avenue,

Suite 6014,

Chicago, IL 60611,

United States

Website: https://www.reporthive.comEmail: [emailprotected]Phone:+1 312-604-7084

Originally posted here:
Covid-19 Impact On Radiocontrast Agent Market 2020: Global Industry Overview By Top Key Players Analysis And Growth Factors Up To 2025| GE Healthcare...

Global Nanomedicine Market report provides you with detailed insights, industry knowledge, market forecasts and analytics. The report on the global Nanomedicine industry also clarifies economic risks and environmental compliance. Global Nanomedicine market report assists industry enthusiasts including investors and decision makers to make confident capital investments, develop strategies, optimize their business portfolio, innovate successfully and perform safely and sustainably.

Request Sample Copy of this Report @ https://prominentmarketresearch.com/sample-report/121190

Key Companies

The report offers detailed coverage of Nanomedicine industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Nanomedicine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://prominentmarketresearch.com/inquiry-report/121190

Key Product Type

Market by Application

Nanomedicine Market Segment by Regions

Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania

Europe: Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland

North America: United States, Canada, Mexico

Middle East & Africa: GCC, North Africa, South Africa

South America: Brazil, Argentina, Columbia, Chile, Peru

The key points of the Nanomedicine Market report:

Get Complete Report in your Inbox within 24 hours @ https://prominentmarketresearch.com/checkout/121190

Global Nanomedicine Market providing information such as company profiles, product picture, and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis are also carried out. The Global Nanomedicine market development trends and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered.

Key Points from Table of Content

1 Nanomedicine Industrial Chain Overview2 Global Nanomedicine Market Production & Consumption by Geography3 Nanomedicine Market Major Manufacturers Introduction4 Nanomedicine Market Competition Pattern5 Nanomedicine Product Type Segment6 Nanomedicine End-Use Segment7 Nanomedicine Market Forecast & Trend8 Nanomedicine Price & Channel9 Nanomedicine Market Drivers & Investment Environment10 Research Conclusion

* If you need anything more than these then let us know and we will prepare the report according to your requirement.

About Us

Prominent Market Research has an extensive coverage of diligence verticals of qualitative and quantitative reports across all the industries. In case your needs are not met by syndicated reports untaken by the foremost publishers, we can help you by proposing a customized research elucidation by liaising with different research interventions saving your valuable time and money. We have experienced and trained staff that helps you navigate different options and lets you choose preeminent research solution at most effective cost.

Contact Us

Michael, Sales Manager

Prominent Market Research

7309 Woodward Ave,

Apt 107, Woodridge, Illinois, USA, 60517

Phone: USA +1-630-361-6262

Email: [emailprotected]

Corporate Sales: [emailprotected]

See the original post:
Nanomedicine Market by Key Manufacturers, Regions, Risk Analysis, Industry Share, Driving Factors, Deployment Policy, Innovative Technology, Product...

driven by a revised compounded annual growth rate (CAGR) of 22. 6%. Nanocrystals, one of the segments analyzed and sized in this study, is forecast to grow at over 20. 2% and reach a market size of US$83.

New York, May 27, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nanotechnology in Drug Delivery Industry" - https://www.reportlinker.com/p05621749/?utm_source=GNW 1 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Nanocrystals market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 17% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$4.1 Billion to the regions size over the next 7 to 8 years. In addition, over US$3.7 Billion worth of projected demand in the region will come from Rest of European markets. In Japan, the Nanocrystals segment will reach a market size of US$3 Billion by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Nanotechnology in Drug Delivery market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the worlds second largest economy will grow at 25.2% over the next couple of years and add approximately US$20.2 Billion in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Nanotechnology in Drug Delivery market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, AbbVie Inc.; Aquanova AG; BlueWillow Biologics; Camurus AB; Celgene, Inc.; Ceramisphere Health Pty Limited; Cristal Therapeutics; CYTIMMUNE SCIENCES, Inc.; EnColl Corporation; EyePoint Pharmaceuticals; Lena Nanoceutics Ltd.; Nanobiotix; NanoCarrier Co., Ltd.; NanOlogy LLC; Nanospectra Biosciences, Inc.; Parvus Therapeutics Inc.; Selecta Biosciences; Starpharma Holdings Limited; Taiwan Liposome Co., ; Tarveda Therapeutics

Read the full report: https://www.reportlinker.com/p05621749/?utm_source=GNW

NANOTECHNOLOGY IN DRUG DELIVERY MCP-7MARKET ANALYSIS, TRENDS, AND FORECASTS, JUNE 2CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW Nanotechnology, A Critical Part of Healthcare Reform Recent Market Activity Nanomedicine, Revolutionizing the Basics of Medicine A Peek Into the Evolving Role of Nanoparticles in Nanomedicine Nanocrystals Continue to Gain Momentum as Alternatives to Traditional Nanocarriers Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery Multifunctional Dendrimers Present an Ideal Structure for Targeted Drug Delivery High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems Nanotechnology-Based Strategies for siRNA Grows in Popularity NEM Devices as Drug Delivery Vehicles Nanotechnology - In Pursuit of Co-Delivery of Drugs Nanoemulsions Begin to Make a Mark Nanotechnology Finds Increasing Role in Fighting Infectious Diseases List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use Nanotechnology Opening New Avenues in Antiretroviral Therapy Demonstrated Activity of Select Nanotechnology- Delivered Antiretroviral Therapies Nanotechnology in Delivery of CNS Therapeutics Market Outlook Global Competitor Market Shares Nanotechnology in Drug Delivery Competitor Market Share Scenario Worldwide (in %): 2020 & 2029 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS AbbVie Inc. (USA) Aquanova AG (Germany) BlueWillow Biologics (USA) Camurus AB (Sweden) Celgene, Inc. (Canada) Ceramisphere Health Pty Limited (Australia) Cristal Therapeutics (The Netherlands) CYTIMMUNE SCIENCES, INC. (Italy) EnColl Corporation (USA) EyePoint Pharmaceuticals (USA) Lena Nanoceutics Ltd. (UK) NanOlogy LLC (USA) NanoCarrier Co., Ltd. (Japan) Nanobiotix (France) Nanospectra Biosciences, Inc (USA) Parvus Therapeutics Inc. (USA) Selecta Biosciences (USA) Starpharma Holdings Limited (Australia) Taiwan Liposome Co. (Taiwan) Tarveda Therapeutics (USA) 3. MARKET TRENDS & DRIVERS Growing Need for Alternative Approaches to Conventional Chemotherapy Creates Opportunities for Nanoparticles Stimuli Responsive Polymeric Micelles Promise Enhanced Therapeutic Effect for Hydrophobic Anticancer Drugs Inorganic Nanocarriers Facilitate High Payload Capacity and Co -Delivery Platforms for MDR Cancer Therapy Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery SLNs in Pulmonary Delivery of Drugs Market Challenges Increasing Environmental and Health Concerns Limited Success and Scaling Up Issues Pose a Major Hurdle to Further Advancement Higher Concentration of Research in Academia limits Commercialization Collaborations Assume Importance Nanomedicine Regulation 4. GLOBAL MARKET PERSPECTIVE Table 1: Nanotechnology in Drug Delivery Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 2: Nanotechnology in Drug Delivery Market Share Shift across Key Geographies Worldwide: 2020 VS 2027 Table 3: Nanocrystals (Technology) World Market by Region/Country in US$ Million: 2020 to 2027 Table 4: Nanocrystals (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027 Table 5: Nanocarriers (Technology) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 Table 6: Nanocarriers (Technology) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Nanotechnology in Drug Delivery Market Share (in %) by Company: 2020 & 2025 Market Analytics Table 7: Nanotechnology in Drug Delivery Market in US$ Million in the United States by Technology: 2020-2027 Table 8: United States Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 CANADA Table 9: Nanotechnology in Drug Delivery Market Analysis in Canada in US$ Million by Technology: 2020-2027 Table 10: Canadian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 JAPAN Table 11: Japanese Medium & Long-Term Outlook for Nanotechnology in Drug Delivery Market in US$ Million by Technology: 2020-2027 Table 12: Japanese Nanotechnology in Drug Delivery Market Percentage Share Distribution by Technology: 2020 VS 2027 CHINA Table 13: Nanotechnology in Drug Delivery Market Estimates and Forecasts in China in US$ Million by Technology: 2020-2027 Table 14: Nanotechnology in Drug Delivery Market in China: Percentage Share Analysis by Technology for 2020 and 2027 EUROPE Market Facts & Figures European Nanotechnology in Drug Delivery Market: Competitor Market Share Scenario (in %) for 2020 & 2025 Market Analytics Table 15: European Nanotechnology in Drug Delivery Market Demand Scenario in US$ Million by Region/Country: 2018-2025 Table 16: European Nanotechnology in Drug Delivery Market Share Shift by Region/Country: 2020 VS 2027 Table 17: European Nanotechnology in Drug Delivery Market Assessment in US$ Million by Technology: 2020-2027 Table 18: Nanotechnology in Drug Delivery Market in Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027 FRANCE Table 19: French Nanotechnology in Drug Delivery Market Estimates and Projections in US$ Million by Technology: 2020-2027 Table 20: French Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 GERMANY Table 21: German Nanotechnology in Drug Delivery Latent Demand Forecasts in US$ Million by Technology: 2020-2027 Table 22: German Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 ITALY Table 23: Nanotechnology in Drug Delivery Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020-2027 Table 24: Nanotechnology in Drug Delivery Market in Italy: Percentage Share Analysis by Technology for 2020 and 2027 UNITED KINGDOM Table 25: United Kingdom Medium & Long-Term Outlook for Nanotechnology in Drug Delivery Market in US$ Million by Technology: 2020-2027 Table 26: United Kingdom Nanotechnology in Drug Delivery Market Percentage Share Distribution by Technology: 2020 VS 2027 SPAIN Table 27: Nanotechnology in Drug Delivery Market Analysis in Spain in US$ Million by Technology: 2020-2027 Table 28: Spanish Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 RUSSIA Table 29: Nanotechnology in Drug Delivery Market in US$ Million in Russia by Technology: 2020-2027 Table 30: Russian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 REST OF EUROPE Table 31: Rest of Europe Nanotechnology in Drug Delivery Market Assessment in US$ Million by Technology: 2020-2027 Table 32: Nanotechnology in Drug Delivery Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2and 2027 ASIA-PACIFIC Table 33: Asia-Pacific Nanotechnology in Drug Delivery Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 34: Asia-Pacific Nanotechnology in Drug Delivery Market Share Analysis by Region/Country: 2020 VS 2027 Table 35: Asia-Pacific Nanotechnology in Drug Delivery Market Estimates and Projections in US$ Million by Technology: 2020-2027 Table 36: Asia-Pacific Nanotechnology in Drug Delivery Historic Market Analysis in US$ Million by Technology: 2020 VS 2027 AUSTRALIA Table 37: Australian Nanotechnology in Drug Delivery Latent Demand Forecasts in US$ Million by Technology: 2020-2027 Table 38: Australian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 INDIA Table 39: Nanotechnology in Drug Delivery Market Analysis in India in US$ Million by Technology: 2020-2027 Table 40: Indian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 SOUTH KOREA Table 41: Nanotechnology in Drug Delivery Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Technology for the Period 2020-2027 Table 42: Nanotechnology in Drug Delivery Market Share Distribution in South Korea by Technology: 2020 VS 2027 REST OF ASIA-PACIFIC Table 43: Rest of Asia-Pacific Medium & Long-Term Outlook for Nanotechnology in Drug Delivery Market in US$ Million by Technology: 2020-2027 Table 44: Rest of Asia-Pacific Nanotechnology in Drug Delivery Market Percentage Share Distribution by Technology: 2020 VS 2027 LATIN AMERICA Table 45: Latin American Nanotechnology in Drug Delivery Market Trends by Region/Country in US$ Million: 2020-2027 Table 46: Latin American Nanotechnology in Drug Delivery Market Percentage Breakdown of Sales by Region/Country: 2020 and 2027 Table 47: Nanotechnology in Drug Delivery Market Estimates and Forecasts in Latin America in US$ Million by Technology: 2020-2027 Table 48: Nanotechnology in Drug Delivery Market in Latin America : Percentage Analysis by Technology for 2020 and 2027 ARGENTINA Table 49: Argentinean Nanotechnology in Drug Delivery Market Assessment in US$ Million by Technology: 2020-2027 Table 50: Nanotechnology in Drug Delivery Market in Argentina: Percentage Breakdown of Sales by Technology for 2020 and 2027 BRAZIL Table 51: Brazilian Nanotechnology in Drug Delivery Market Estimates and Projections in US$ Million by Technology: 2020-2027 Table 52: Brazilian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 MEXICO Table 53: Mexican Nanotechnology in Drug Delivery Latent Demand Forecasts in US$ Million by Technology: 2020-2027 Table 54: Mexican Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 REST OF LATIN AMERICA Table 55: Nanotechnology in Drug Delivery Market in US$ Million in Rest of Latin America by Technology: 2020-2027 Table 56: Rest of Latin America Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 MIDDLE EAST Table 57: The Middle East Nanotechnology in Drug Delivery Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 Table 58: The Middle East Nanotechnology in Drug Delivery Market Share Breakdown by Region/Country: 2020 and 2027 Table 59: The Middle East Nanotechnology in Drug Delivery Market Analysis in US$ Million by Technology: 2020-2027 Table 60: The Middle East Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 IRAN Table 61: Iranian Medium & Long-Term Outlook for Nanotechnology in Drug Delivery Market in US$ Million by Technology: 2020-2027 Table 62: Iranian Nanotechnology in Drug Delivery Market Percentage Share Distribution by Technology: 2020 VS 2027 ISRAEL Table 63: Israeli Nanotechnology in Drug Delivery Market Assessment in US$ Million by Technology: 2020-2027 Table 64: Nanotechnology in Drug Delivery Market in Israel: Percentage Breakdown of Sales by Technology for 2020 and 2027 SAUDI ARABIA Table 65: Nanotechnology in Drug Delivery Market Estimates and Forecasts in Saudi Arabia in US$ Million by Technology: 2020-2027 Table 66: Nanotechnology in Drug Delivery Market in Saudi Arabia: Percentage Share Analysis by Technology for 2020 and 2027 UNITED ARAB EMIRATES Table 67: Nanotechnology in Drug Delivery Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Technology for the Period 2020-2027 Table 68: Nanotechnology in Drug Delivery Market Share Distribution in United Arab Emirates by Technology: 2020 VS 2027 REST OF MIDDLE EAST Table 69: Rest of Middle East Nanotechnology in Drug Delivery Latent Demand Forecasts in US$ Million by Technology: 2020-2027 Table 70: Rest of Middle East Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 AFRICA Table 71: Nanotechnology in Drug Delivery Market in US$ Million in Africa by Technology: 2020-2027 Table 72: African Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 IV. COMPETITION

Total Companies Profiled: 43 Read the full report: https://www.reportlinker.com/p05621749/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Read more:
Amid the COVID-19 crisis and the looming economic recession, the Nanotechnology in Drug Delivery market worldwide will grow by a projected US$124.7...

UPDATE AVAILABLE ON-DEMAND

The globalnanomedicine marketwas valued at $111,912 million in 2016, and is projected to reach $261,063 million by 2023, growing at a CAGR of 12.6% from 2017 to 2023. The drug delivery segment accounted for nearly two-fifths share of the global market in 2016.

Nanomedicine is an application of nanotechnology that deals in the prevention & treatment of diseases in humans. This technology uses submicrometer-sized particles for diagnosis, treatment, and prevention of diseases. Nanomedicines are advantageous over generic drugs in several aspects such as, to reduce renal excretion, improve the ability of drugs to accumulate at pathological sites, and enhance the therapeutic index of drugs. Thus, nanomedicine is used in a wide range of applications that include aerospace materials, cosmetics, and medicine.

Download Free Report Sample @https://www.alliedmarketresearch.com/request-sample/2021

The global market is driven by increase in the development of nanotechnology-based drugs, advantages of nanomedicine in various healthcare applications, and growth in need of therapies with fewer side effects. However, long approval process and risks associated with nanomedicine (environmental impacts) restrain the market growth. In addition, growth of healthcare facilities in emerging economies is anticipated to provide numerous opportunities for the market growth.

The vaccines segment is expected to register a significant CAGR of 13.2% throughout the forecast period. The treatment segment accounted for about fourth-sevenths share in the global market in 2016, accounting for the highest share during the forecast period. This is due to the high demand for therapeutics among patient and rise in the incidence of chronic diseases.

The neurological diseases segment is expected to grow at the highest CAGR of 13.9% during the forecast period, owing to high demand for brain monitoring & treatment devices and drugs. The oncological diseases segment accounted for the highest revenue in 2016, with one-third share of the global market, and is expected to maintain its dominance throughout the forecast period.

Get a purchase Enquiry @https://www.alliedmarketresearch.com/purchase-enquiry/2021

In 2016, Asia-Pacific and LAMEA collectively accounted for about one-fourth share of the global market, and is expected to continue this trend due to increased adoption of nanomedicines, especially in China, India, and the other developing economies. In addition, rise in investments by key players in the field of nanomedicines is key driving factor of the Asia-Pacific market.

The Major Key Players Are:

Abbott Laboratories, CombiMatrix Corporation, General Electric Company, Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., and Teva Pharmaceutical Industries Ltd.

The other prominent players Are:

Celgene Corporation, UCB (Union Chimique Belge) S.A., AMAG Pharmaceuticals, Nanospectra Biosciences, Inc., Arrowhead Pharmaceuticals, Inc., Leadiant Biosciences, Inc., Epeius Biotechnologies Corporation, Gilead, and Cytimmune Sciences, Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying:https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information:https://www.alliedmarketresearch.com/library-access

Similar Reports:

India Disposable Gloves Market

ASEAN Blood Pressure Monitoring Devices Market

North America Medical Tourism Market

Companion Diagnostic Market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies clients insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesUSA/Canada (Toll Free):+1-800-792-5285, +1-503-894-6022, +1-503-446-1141UK:+44-845-528-1300Hong Kong:+852-301-84916India (Pune):+91-20-66346060Fax:+1(855)550-5975help@alliedmarketresearch.comWeb:https://www.alliedmarketresearch.comMarket Pulse:https://blog.alliedmarketresearch.comFollow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at contact@wiredrelease.com.

Go here to read the rest:
Nanomedicine Market to Witness Increasing Growth $261063 Million at CAGR of 12.6% In 2023 - PharmiWeb.com

A supply ship rocketed toward the International Space Station on Saturday with sports car parts, an oven for baking cookies and a vest to protect against radiation.

Northrop Grumman launched its Cygnus capsule for NASA from Wallops Island, Virginia. The 8,200-pound shipment (3,700 kilograms) should reach the orbiting lab Monday.

"Good launch all the way around," a ground controller observed.

The space station's astronauts will test the oven by baking chocolate chip cookies and try out the new safety vest to gauge its comfort. Both experiments are seen as precursors to moon and Mars journeys.

Other newly arriving equipment will be used in a series of NASA spacewalks later this month to fix a key particle physics detector. Parked outside the space station since 2011, the Alpha Magnetic Spectrometer needs new cooling pumps to continue its search for elusive dark matter and antimatter.

Italy's Lamborghini is also along for the ride. It's sending up samples of carbon fiber used in its sports cars for six months of direct space exposure. Researchers are considering the materials for medical implants.

Like space, the insides of a person's body are an extreme environment, explained Houston Methodist's Alessandro Grattoni, who is collaborating with Lamborghini on the experiment. As a nanomedicine specialist, he said Friday he's continuously on the lookout for new materials for devices that are inserted beneath the skin. These minuscule implants release therapeutic drugs to treat cancer, hormone deficiencies and other illnesses.

Northrop Grumman is now controlling two Cygnus capsules in orbit, a first for the Virginia-based company. Named for the swan constellation, the Cygnus launched last spring is flying free of the 250-mile-high (400-kilometer-high) space station, after completing its grocery run. It will be directed to a fiery re-entry sometime in the near future, taking station trash down with it, according to company officials.

The newest Cygnus is officially called the S.S. Alan Bean after the Apollo 12 astronaut who became the fourth man to walk on the moon 50 years ago this month. He later commanded NASA's first space station, Skylab, and became known for his cosmic-themed paintings. He died last year.

NASA has contracted with Northrop Grumman and SpaceX to keep the space station stocked. This is Northrop Grumman's 12th successful Cygnus flight since 2013. The company has upgraded both its Cygnus and Antares rocket to haul more cargo from NASA's Wallops Flight Facility on the eastern Virginia shore.

The space station is currently home to three Americans, two Russians and one Italian.

Continue reading here:
Space Shipment Launched With Sports Car Parts, Cookie Oven - The New York Times